Integrins in cancer: biological implications and therapeutic opportunities
Тип публикации: Journal Article
Дата публикации: 2010-01-01
scimago Q1
wos Q1
БС1
SJR: 24.378
CiteScore: 103.8
Impact factor: 66.8
ISSN: 1474175X, 14741768
PubMed ID:
20029421
General Environmental Science
General Earth and Planetary Sciences
Краткое описание
The integrins regulate a diverse array of cellular functions that are crucial to the initiation, progression and metastasis of solid tumours. This Review discusses the exciting developments in targeting integrins, including the recent initiation of a Phase III trial for an integrin antagonist in patients with glioblastoma. The integrin family of cell adhesion receptors regulates a diverse array of cellular functions crucial to the initiation, progression and metastasis of solid tumours. The importance of integrins in several cell types that affect tumour progression has made them an appealing target for cancer therapy. Integrin antagonists, including the αvβ3 and αvβ5 inhibitor cilengitide, have shown encouraging activity in Phase II clinical trials and cilengitide is currently being tested in a Phase III trial in patients with glioblastoma. These exciting clinical developments emphasize the need to identify how integrin antagonists influence the tumour and its microenvironment.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
10
20
30
40
50
60
70
80
|
|
|
Cancers
79 публикаций, 2.58%
|
|
|
Oncotarget
66 публикаций, 2.16%
|
|
|
International Journal of Molecular Sciences
53 публикации, 1.73%
|
|
|
Scientific Reports
53 публикации, 1.73%
|
|
|
PLoS ONE
49 публикаций, 1.6%
|
|
|
Frontiers in Oncology
43 публикации, 1.4%
|
|
|
Oncogene
35 публикаций, 1.14%
|
|
|
Journal of Controlled Release
32 публикации, 1.05%
|
|
|
Cancer Research
32 публикации, 1.05%
|
|
|
Pharmaceutics
25 публикаций, 0.82%
|
|
|
Cancer Letters
24 публикации, 0.78%
|
|
|
Advanced Drug Delivery Reviews
23 публикации, 0.75%
|
|
|
Bioconjugate Chemistry
23 публикации, 0.75%
|
|
|
Molecular Pharmaceutics
22 публикации, 0.72%
|
|
|
Nature Communications
21 публикация, 0.69%
|
|
|
Biomaterials
21 публикация, 0.69%
|
|
|
Frontiers in Cell and Developmental Biology
20 публикаций, 0.65%
|
|
|
Journal of Biological Chemistry
19 публикаций, 0.62%
|
|
|
Cells
18 публикаций, 0.59%
|
|
|
Angewandte Chemie - International Edition
17 публикаций, 0.56%
|
|
|
Angewandte Chemie
17 публикаций, 0.56%
|
|
|
Journal of Medicinal Chemistry
16 публикаций, 0.52%
|
|
|
Biochemical and Biophysical Research Communications
16 публикаций, 0.52%
|
|
|
Experimental Cell Research
16 публикаций, 0.52%
|
|
|
Molecular Cancer Therapeutics
16 публикаций, 0.52%
|
|
|
Journal of Cell Science
15 публикаций, 0.49%
|
|
|
International Journal of Cancer
15 публикаций, 0.49%
|
|
|
ACS Nano
15 публикаций, 0.49%
|
|
|
Journal of Materials Chemistry B
14 публикаций, 0.46%
|
|
|
10
20
30
40
50
60
70
80
|
Издатели
|
100
200
300
400
500
600
700
|
|
|
Elsevier
642 публикации, 20.97%
|
|
|
Springer Nature
556 публикаций, 18.16%
|
|
|
Wiley
314 публикаций, 10.26%
|
|
|
MDPI
268 публикаций, 8.76%
|
|
|
American Chemical Society (ACS)
170 публикаций, 5.55%
|
|
|
Frontiers Media S.A.
114 публикаций, 3.72%
|
|
|
Taylor & Francis
98 публикаций, 3.2%
|
|
|
Royal Society of Chemistry (RSC)
91 публикация, 2.97%
|
|
|
Impact Journals
69 публикаций, 2.25%
|
|
|
American Association for Cancer Research (AACR)
69 публикаций, 2.25%
|
|
|
Public Library of Science (PLoS)
53 публикации, 1.73%
|
|
|
Cold Spring Harbor Laboratory
44 публикации, 1.44%
|
|
|
Spandidos Publications
40 публикаций, 1.31%
|
|
|
Hindawi Limited
36 публикаций, 1.18%
|
|
|
Oxford University Press
32 публикации, 1.05%
|
|
|
SAGE
27 публикаций, 0.88%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
24 публикации, 0.78%
|
|
|
American Society for Biochemistry and Molecular Biology
21 публикация, 0.69%
|
|
|
Bentham Science Publishers Ltd.
20 публикаций, 0.65%
|
|
|
The Company of Biologists
20 публикаций, 0.65%
|
|
|
Mary Ann Liebert
17 публикаций, 0.56%
|
|
|
American Association for the Advancement of Science (AAAS)
16 публикаций, 0.52%
|
|
|
American Society for Clinical Investigation
13 публикаций, 0.42%
|
|
|
Rockefeller University Press
12 публикаций, 0.39%
|
|
|
Society of Nuclear Medicine
11 публикаций, 0.36%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
11 публикаций, 0.36%
|
|
|
Walter de Gruyter
9 публикаций, 0.29%
|
|
|
American Physiological Society
9 публикаций, 0.29%
|
|
|
Bioscientifica
8 публикаций, 0.26%
|
|
|
100
200
300
400
500
600
700
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
3.1k
Всего цитирований:
3064
Цитирований c 2025:
190
(6.21%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Desgrosellier J. S., Cheresh D. A. Integrins in cancer: biological implications and therapeutic opportunities // Nature Reviews Cancer. 2010. Vol. 10. No. 1. pp. 9-22.
ГОСТ со всеми авторами (до 50)
Скопировать
Desgrosellier J. S., Cheresh D. A. Integrins in cancer: biological implications and therapeutic opportunities // Nature Reviews Cancer. 2010. Vol. 10. No. 1. pp. 9-22.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1038/nrc2748
UR - https://doi.org/10.1038/nrc2748
TI - Integrins in cancer: biological implications and therapeutic opportunities
T2 - Nature Reviews Cancer
AU - Desgrosellier, Jay S
AU - Cheresh, David A
PY - 2010
DA - 2010/01/01
PB - Springer Nature
SP - 9-22
IS - 1
VL - 10
PMID - 20029421
SN - 1474-175X
SN - 1474-1768
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2010_Desgrosellier,
author = {Jay S Desgrosellier and David A Cheresh},
title = {Integrins in cancer: biological implications and therapeutic opportunities},
journal = {Nature Reviews Cancer},
year = {2010},
volume = {10},
publisher = {Springer Nature},
month = {jan},
url = {https://doi.org/10.1038/nrc2748},
number = {1},
pages = {9--22},
doi = {10.1038/nrc2748}
}
Цитировать
MLA
Скопировать
Desgrosellier, Jay S., and David A Cheresh. “Integrins in cancer: biological implications and therapeutic opportunities.” Nature Reviews Cancer, vol. 10, no. 1, Jan. 2010, pp. 9-22. https://doi.org/10.1038/nrc2748.